|
Volumn 19, Issue 1, 2011, Pages 121-
|
Clinical utility gene card for: Holoprosencephaly
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DNA FRAGMENT;
EYE PROTEIN;
HOMEODOMAIN PROTEIN;
NERVE PROTEIN;
NUCLEAR PROTEIN;
SHH PROTEIN, HUMAN;
SINE OCULIS HOMEOBOX HOMOLOG 3 PROTEIN;
SONIC HEDGEHOG PROTEIN;
TRANSCRIPTION FACTOR;
ZIC2 PROTEIN, HUMAN;
ANALYTIC METHOD;
BRAIN MALFORMATION;
CLINICAL FEATURE;
COMPARATIVE GENOMIC HYBRIDIZATION;
CRANIOFACIAL MALFORMATION;
DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
DNA DENATURATION;
ETHNIC GROUP;
FLUORESCENCE IN SITU HYBRIDIZATION;
GENE;
GENE REARRANGEMENT;
GENE SEQUENCE;
HETEROZYGOTE;
HOLOPROSENCEPHALY;
HUMAN;
MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION;
MUTATION RATE;
NOTE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
POINT MUTATION;
PREDICTION AND FORECASTING;
PREVALENCE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
STATISTICAL ANALYSIS;
ARTICLE;
GENETICS;
PREDICTIVE VALUE;
EYE PROTEINS;
HEDGEHOG PROTEINS;
HOLOPROSENCEPHALY;
HOMEODOMAIN PROTEINS;
HUMANS;
NERVE TISSUE PROTEINS;
NUCLEAR PROTEINS;
POINT MUTATION;
PREDICTIVE VALUE OF TESTS;
SENSITIVITY AND SPECIFICITY;
TRANSCRIPTION FACTORS;
|
EID: 78650058858
PISSN: 10184813
EISSN: 14765438
Source Type: Journal
DOI: 10.1038/ejhg.2010.110 Document Type: Note |
Times cited : (12)
|
References (6)
|